威鋮國際(01002.HK)年度收入同比減少52.62%至1.21億元
格隆匯9月26日丨威鋮國際(01002.HK)公吿,截至2022年7月31日止財政年度業績,收入減少52.62%至人民幣1.21億元;公司擁有人應占年內虧損為人民幣4825萬元;每股基本虧損為人民幣2.09分。
集團收入主要來自塑膠注塑成型業務,佔集團收入73.24%(2021年:60.15%),其餘則來自其裝配電子產品業務以及模具設計與制模業務,分別佔集團收入24.24%(2021年:37.37%)及2.52%(2021年:2.48%)。
收入減少乃主要由於一名於2022年停止業務營運的客户於歐洲及美利堅合眾國的訂單量下降所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.